Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kluth

Showing results (641-650 of 1,145) with videos related to

Pageof 115
Sort By:
Clinical Genitourinary Cancer|May 11, 2021
Radical Cystectomy vs. Multimodality Treatment in T2N0M0 Bladder Cancer: A Population-based, Age-matched AnalysisMarina Deuker, Marieke J Krimphove, L Franziska Stolzenbach, et al.
Cancers|March 10, 2022
Effect of Neoadjuvant Chemotherapy on Complications, in-Hospital Mortality, Length of Stay and Total Hospital Costs in Bladder Cancer Patients Undergoing Radical CystectomyBenedikt Hoeh, Rocco Simone Flammia, Lukas Hohenhorst, et al.
Genes, Chromosomes & Cancer|June 21, 2018
13q deletion is linked to an adverse phenotype and poor prognosis in prostate cancerMartina Kluth, Sekander Scherzai, Franziska Büschek, et al.
Pathology International|August 11, 2020
High B7-H3 expression is linked to increased risk of prostate cancer progressionSarah Bonk, Pinar Tasdelen, Martina Kluth, et al.
The Prostate|July 7, 2020
Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG-negative prostate cancerSarah Bonk, Martina Kluth, Kristina Jansen, et al.
Blood|May 27, 2016
Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapyCarmen Diana Herling, Marion Klaumünzer, Cristiano Krings Rocha, et al.
Surgical Oncology|March 22, 2023
Regional differences in total hospital costs for radical cystectomy in the United StatesBenedikt Hoeh, Rocco Simone Flammia, Lukas Hohenhorst, et al.
European Journal of Cancer (Oxford, England : 1990)|July 3, 2007
DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients--Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology groupSabine Maier, Inko Nimmrich, Thomas Koenig, et al.
Cancer Gene Therapy|January 8, 2021
CHD1 loss negatively influences metastasis-free survival in R0-resected prostate cancer patients and promotes spontaneous metastasis in vivoSu Jung Oh-Hohenhorst, Derya Tilki, Ann-Kristin Ahlers, et al.
Virchows Archiv : an International Journal of Pathology|August 6, 2024
PAX8 expression in cancerous and non-neoplastic tissue: a tissue microarray study on more than 17,000 tumors from 149 different tumor entitiesNatalia Gorbokon, Sarah Baltruschat, Maximilian Lennartz, et al.
Pageof 115

Showing results (641-650 of 1,145) with videos related to

Sort By:
Pageof 115
Clinical Genitourinary Cancer|May 11, 2021
Radical Cystectomy vs. Multimodality Treatment in T2N0M0 Bladder Cancer: A Population-based, Age-matched AnalysisMarina Deuker, Marieke J Krimphove, L Franziska Stolzenbach, et al.
Cancers|March 10, 2022
Effect of Neoadjuvant Chemotherapy on Complications, in-Hospital Mortality, Length of Stay and Total Hospital Costs in Bladder Cancer Patients Undergoing Radical CystectomyBenedikt Hoeh, Rocco Simone Flammia, Lukas Hohenhorst, et al.
Genes, Chromosomes & Cancer|June 21, 2018
13q deletion is linked to an adverse phenotype and poor prognosis in prostate cancerMartina Kluth, Sekander Scherzai, Franziska Büschek, et al.
Pathology International|August 11, 2020
High B7-H3 expression is linked to increased risk of prostate cancer progressionSarah Bonk, Pinar Tasdelen, Martina Kluth, et al.
The Prostate|July 7, 2020
Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG-negative prostate cancerSarah Bonk, Martina Kluth, Kristina Jansen, et al.
Blood|May 27, 2016
Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapyCarmen Diana Herling, Marion Klaumünzer, Cristiano Krings Rocha, et al.
Surgical Oncology|March 22, 2023
Regional differences in total hospital costs for radical cystectomy in the United StatesBenedikt Hoeh, Rocco Simone Flammia, Lukas Hohenhorst, et al.
European Journal of Cancer (Oxford, England : 1990)|July 3, 2007
DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients--Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology groupSabine Maier, Inko Nimmrich, Thomas Koenig, et al.
Cancer Gene Therapy|January 8, 2021
CHD1 loss negatively influences metastasis-free survival in R0-resected prostate cancer patients and promotes spontaneous metastasis in vivoSu Jung Oh-Hohenhorst, Derya Tilki, Ann-Kristin Ahlers, et al.
Virchows Archiv : an International Journal of Pathology|August 6, 2024
PAX8 expression in cancerous and non-neoplastic tissue: a tissue microarray study on more than 17,000 tumors from 149 different tumor entitiesNatalia Gorbokon, Sarah Baltruschat, Maximilian Lennartz, et al.
Pageof 115